Trial description:
Renal Adjuvant MultiPle Arm Randomised Trial (RAMPART): An international investigator-led phase III multi-arm multi-stage multi-centre randomised-controlled platform trial of adjuvant therapy in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse
Contact name:
Dr Sarah Welsh
Trial start date:
Friday, July 20, 2018
Trial end date:
Sunday, December 31, 2023
Trial tumour type:
Kidney
Show on Radiotherapy:
No
